| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -2.29M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ESLA returned -25.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -53.5% |
| 1 year | -25.3% |
| All-time high | $10.84 (Jun 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ESLA would be worth today ›No. Estrella Immunopharma, Inc. has not paid a dividend in the past 12 months.
Estrella Immunopharma, Inc. stock trades on NASDAQ under the ticker symbol ESLA.
Estrella Immunopharma, Inc. is part of the Healthcare sector.
Estrella Immunopharma, Inc. has a market cap of 31.53M USD, based on the latest quote.
